669 related articles for article (PubMed ID: 30318143)
1. Evolution of Metastases in Space and Time under Immune Selection.
Angelova M; Mlecnik B; Vasaturo A; Bindea G; Fredriksen T; Lafontaine L; Buttard B; Morgand E; Bruni D; Jouret-Mourin A; Hubert C; Kartheuser A; Humblet Y; Ceccarelli M; Syed N; Marincola FM; Bedognetti D; Van den Eynde M; Galon J
Cell; 2018 Oct; 175(3):751-765.e16. PubMed ID: 30318143
[TBL] [Abstract][Full Text] [Related]
2. Tumor spread or siege immunity: dissemination to distant metastasis or not.
Bindea G; Mlecnik B; Galon J
Oncoimmunology; 2021 Apr; 10(1):1919377. PubMed ID: 33996269
[TBL] [Abstract][Full Text] [Related]
3. Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases.
Tabariès S; Ouellet V; Hsu BE; Annis MG; Rose AA; Meunier L; Carmona E; Tam CE; Mes-Masson AM; Siegel PM
Breast Cancer Res; 2015 Mar; 17(1):45. PubMed ID: 25882816
[TBL] [Abstract][Full Text] [Related]
4. Cancer immune contexture and immunotherapy.
Becht E; Giraldo NA; Dieu-Nosjean MC; Sautès-Fridman C; Fridman WH
Curr Opin Immunol; 2016 Apr; 39():7-13. PubMed ID: 26708937
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival.
Mlecnik B; Van den Eynde M; Bindea G; Church SE; Vasaturo A; Fredriksen T; Lafontaine L; Haicheur N; Marliot F; Debetancourt D; Pairet G; Jouret-Mourin A; Gigot JF; Hubert C; Danse E; Dragean C; Carrasco J; Humblet Y; Valge-Archer V; Berger A; Pagès F; Machiels JP; Galon J
J Natl Cancer Inst; 2018 Jan; 110(1):. PubMed ID: 28922789
[TBL] [Abstract][Full Text] [Related]
6. [Focus on the Immunoscore and its potential clinical implications].
El Sissy C; Marliot F; Haicheur N; Kirilovsky A; Scripcariu D; Lagorce-Pagès C; Galon J; Pagès F
Ann Pathol; 2017 Feb; 37(1):29-38. PubMed ID: 28161000
[TBL] [Abstract][Full Text] [Related]
7. The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasis.
Mlecnik B; Bindea G; Kirilovsky A; Angell HK; Obenauf AC; Tosolini M; Church SE; Maby P; Vasaturo A; Angelova M; Fredriksen T; Mauger S; Waldner M; Berger A; Speicher MR; Pagès F; Valge-Archer V; Galon J
Sci Transl Med; 2016 Feb; 8(327):327ra26. PubMed ID: 26912905
[TBL] [Abstract][Full Text] [Related]
8. The Role of Tumor-Infiltrating Lymphocytes in Development, Progression, and Prognosis of Non-Small Cell Lung Cancer.
Bremnes RM; Busund LT; Kilvær TL; Andersen S; Richardsen E; Paulsen EE; Hald S; Khanehkenari MR; Cooper WA; Kao SC; Dønnem T
J Thorac Oncol; 2016 Jun; 11(6):789-800. PubMed ID: 26845192
[TBL] [Abstract][Full Text] [Related]
9. The Link between the Multiverse of Immune Microenvironments in Metastases and the Survival of Colorectal Cancer Patients.
Van den Eynde M; Mlecnik B; Bindea G; Fredriksen T; Church SE; Lafontaine L; Haicheur N; Marliot F; Angelova M; Vasaturo A; Bruni D; Jouret-Mourin A; Baldin P; Huyghe N; Haustermans K; Debucquoy A; Van Cutsem E; Gigot JF; Hubert C; Kartheuser A; Remue C; Léonard D; Valge-Archer V; Pagès F; Machiels JP; Galon J
Cancer Cell; 2018 Dec; 34(6):1012-1026.e3. PubMed ID: 30537506
[TBL] [Abstract][Full Text] [Related]
10. Regulation of CTL Infiltration Within the Tumor Microenvironment.
Church SE; Galon J
Adv Exp Med Biol; 2017; 1036():33-49. PubMed ID: 29275463
[TBL] [Abstract][Full Text] [Related]
11. The immune contexture of primary and metastatic human tumours.
Giraldo NA; Becht E; Remark R; Damotte D; Sautès-Fridman C; Fridman WH
Curr Opin Immunol; 2014 Apr; 27():8-15. PubMed ID: 24487185
[TBL] [Abstract][Full Text] [Related]
12. Interfaces of Malignant and Immunologic Clonal Dynamics in Ovarian Cancer.
Zhang AW; McPherson A; Milne K; Kroeger DR; Hamilton PT; Miranda A; Funnell T; Little N; de Souza CPE; Laan S; LeDoux S; Cochrane DR; Lim JLP; Yang W; Roth A; Smith MA; Ho J; Tse K; Zeng T; Shlafman I; Mayo MR; Moore R; Failmezger H; Heindl A; Wang YK; Bashashati A; Grewal DS; Brown SD; Lai D; Wan ANC; Nielsen CB; Huebner C; Tessier-Cloutier B; Anglesio MS; Bouchard-Côté A; Yuan Y; Wasserman WW; Gilks CB; Karnezis AN; Aparicio S; McAlpine JN; Huntsman DG; Holt RA; Nelson BH; Shah SP
Cell; 2018 Jun; 173(7):1755-1769.e22. PubMed ID: 29754820
[TBL] [Abstract][Full Text] [Related]
13. Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications.
Roelands J; Kuppen PJK; Vermeulen L; Maccalli C; Decock J; Wang E; Marincola FM; Bedognetti D; Hendrickx W
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29064420
[TBL] [Abstract][Full Text] [Related]
14. Immunological Consequences of Epithelial-Mesenchymal Transition in Tumor Progression.
Chockley PJ; Keshamouni VG
J Immunol; 2016 Aug; 197(3):691-8. PubMed ID: 27431984
[TBL] [Abstract][Full Text] [Related]
15. Decrease in intrahepatic CD56+ lymphocytes in gastric and colorectal cancer patients with liver metastases.
Gulubova M; Manolova I; Kyurkchiev D; Julianov A; Altunkova I
APMIS; 2009 Dec; 117(12):870-9. PubMed ID: 20078551
[TBL] [Abstract][Full Text] [Related]
16. Immune Contexture, Immunoscore, and Malignant Cell Molecular Subgroups for Prognostic and Theranostic Classifications of Cancers.
Becht E; Giraldo NA; Germain C; de Reyniès A; Laurent-Puig P; Zucman-Rossi J; Dieu-Nosjean MC; Sautès-Fridman C; Fridman WH
Adv Immunol; 2016; 130():95-190. PubMed ID: 26923001
[TBL] [Abstract][Full Text] [Related]
17. Immune cells in the melanoma microenvironment hold information for prediction of the risk of recurrence and response to treatment.
Camisaschi C; Vallacchi V; Castelli C; Rivoltini L; Rodolfo M
Expert Rev Mol Diagn; 2014 Jul; 14(6):643-6. PubMed ID: 24914691
[TBL] [Abstract][Full Text] [Related]
18. Inclusion of BLIMP-1
Ward-Hartstonge KA; McCall JL; McCulloch TR; Kamps AK; Girardin A; Cretney E; Munro FM; Kemp RA
Cancer Immunol Immunother; 2017 Apr; 66(4):515-522. PubMed ID: 28116480
[TBL] [Abstract][Full Text] [Related]
19. Anti-PD-1 increases the clonality and activity of tumor infiltrating antigen specific T cells induced by a potent immune therapy consisting of vaccine and metronomic cyclophosphamide.
Weir GM; Hrytsenko O; Quinton T; Berinstein NL; Stanford MM; Mansour M
J Immunother Cancer; 2016; 4():68. PubMed ID: 27777777
[TBL] [Abstract][Full Text] [Related]
20. Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study.
Romagnoli G; Wiedermann M; Hübner F; Wenners A; Mathiak M; Röcken C; Maass N; Klapper W; Alkatout I
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
